• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

离子液体:口服药物传递的有前途方法。

Ionic Liquids: Promising Approach for Oral Drug Delivery.

机构信息

Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.

Department of Pharmaceutical Analysis, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, People's Republic of China.

出版信息

Pharm Res. 2022 Oct;39(10):2353-2365. doi: 10.1007/s11095-022-03260-8. Epub 2022 Apr 21.

DOI:10.1007/s11095-022-03260-8
PMID:35449344
Abstract

Oral administration is the most preferred route for drug administration in clinic. However, due to unsatisfactory physicochemical properties of drugs and various physiological barriers, the oral bioavailability of most poorly water-soluble and macromolecules drugs is low and the therapeutic effect is unsatisfactory. Ionic liquids (ILs), molten salts with unique properties, show amazing potential for oral delivery. In addition to being able to form active pharmaceutical ingredients based ILs (API-ILs) to overcome drug solubility and polymorphism issues, ILs have also been used to enhance the solubility of poorly soluble drugs, enhance drug stability in the gastrointestinal environment, improve drug permeability in intestinal mucus, and facilitate drug penetration across the intestinal epithelial barrier. Furthermore, ILs were attempted as formulation components to develop novel oral drug delivery systems. This review focus on the application progress of ILs in oral drug delivery and the mechanisms. The challenges and perspectives of the development of ILs-based oral delivery systems are also discussed. This article reviews the latest advances of ionic liquids for oral drug delivery, focusing on the application and related mechanisms of ionic liquids in improving the drug physicochemical properties and enhancing drug delivery across physiological barriers.

摘要

口服是临床给药最首选的途径。然而,由于药物的理化性质不理想和各种生理屏障,大多数水溶性差和大分子药物的口服生物利用度低,治疗效果不佳。离子液体(ILs)是具有独特性质的熔融盐,在口服给药方面显示出惊人的潜力。除了能够形成基于活性药物成分的离子液体(API-ILs)以克服药物溶解度和多晶型问题外,ILs 还被用于提高难溶性药物的溶解度、增强药物在胃肠道环境中的稳定性、提高肠道粘液中药物的渗透性,并促进药物穿透肠上皮屏障。此外,还尝试将 ILs 用作制剂成分来开发新型口服药物传递系统。

本文重点介绍了 ILs 在口服药物传递中的应用进展和相关机制。还讨论了基于 ILs 的口服递药系统发展所面临的挑战和展望。本文综述了离子液体在口服药物传递中的最新进展,重点介绍了离子液体在改善药物物理化学性质和增强药物穿越生理屏障的传递方面的应用和相关机制。

相似文献

1
Ionic Liquids: Promising Approach for Oral Drug Delivery.离子液体:口服药物传递的有前途方法。
Pharm Res. 2022 Oct;39(10):2353-2365. doi: 10.1007/s11095-022-03260-8. Epub 2022 Apr 21.
2
Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.将难溶性药物转化为亲脂性离子液体可提高基于脂质制剂的口服药物暴露量。
Mol Pharm. 2015 Jun 1;12(6):1980-91. doi: 10.1021/mp500790t. Epub 2015 May 5.
3
Polyvinylidene fluoride-Hyaluronic acid wound dressing comprised of ionic liquids for controlled drug delivery and dual therapeutic behavior.聚偏二氟乙烯-透明质酸伤口敷料包含离子液体用于控制药物释放和双重治疗行为。
Acta Biomater. 2019 Dec;100:142-157. doi: 10.1016/j.actbio.2019.10.007. Epub 2019 Oct 4.
4
Ionic liquids as a useful tool for tailoring active pharmaceutical ingredients.离子液体作为一种有用的工具,可用于定制活性药物成分。
J Control Release. 2021 Oct 10;338:268-283. doi: 10.1016/j.jconrel.2021.08.032. Epub 2021 Aug 20.
5
Pharmaceutical Applications of Ionic Liquids: A Personal Account.离子液体在药物中的应用:个人观点。
Chem Rec. 2023 Aug;23(8):e202300026. doi: 10.1002/tcr.202300026. Epub 2023 Apr 12.
6
Ionic Liquids for Therapeutic and Drug Delivery Applications.离子液体在治疗和药物传递应用中的应用。
Curr Drug Res Rev. 2020;12(1):26-41. doi: 10.2174/2589977511666191125103338.
7
Active pharmaceutical ingredients (APIs) in ionic liquids: An effective approach for API physiochemical parameter optimization.离子液体中的活性药物成分(APIs):优化 API 物理化学参数的有效方法。
Drug Discov Today. 2022 Sep;27(9):2415-2424. doi: 10.1016/j.drudis.2022.06.003. Epub 2022 Jun 11.
8
Applications of choline-based ionic liquids in drug delivery.胆碱基离子液体在药物传递中的应用。
Int J Pharm. 2022 Jan 25;612:121366. doi: 10.1016/j.ijpharm.2021.121366. Epub 2021 Dec 9.
9
Ionic liquid-based formulation approaches for enhanced transmucosal drug delivery.基于离子液体的制剂方法增强经黏膜药物传递。
Drug Discov Today. 2024 Sep;29(9):104109. doi: 10.1016/j.drudis.2024.104109. Epub 2024 Jul 19.
10
Ionic Liquids for Enhanced Drug Delivery: Recent Progress and Prevailing Challenges.离子液体在药物传递中的应用:最新进展与现存挑战。
Mol Pharm. 2022 Apr 4;19(4):1033-1046. doi: 10.1021/acs.molpharmaceut.1c00960. Epub 2022 Mar 11.

引用本文的文献

1
Ionic liquids self-assembled micelles for transdermal delivery: characterization, functions and applications.用于透皮给药的离子液体自组装胶束:表征、功能及应用
Int J Pharm X. 2025 Jun 30;10:100350. doi: 10.1016/j.ijpx.2025.100350. eCollection 2025 Dec.
2
Rose Bengal-Chitosan Nanocomposites for Oral Administration.用于口服给药的孟加拉玫瑰红-壳聚糖纳米复合材料
Nanomaterials (Basel). 2025 May 8;15(10):706. doi: 10.3390/nano15100706.
3
An Overview on the Role of Ionic Liquids and Deep Eutectic Solvents in Oral Pharmaceuticals.

本文引用的文献

1
Applications of choline-based ionic liquids in drug delivery.胆碱基离子液体在药物传递中的应用。
Int J Pharm. 2022 Jan 25;612:121366. doi: 10.1016/j.ijpharm.2021.121366. Epub 2021 Dec 9.
2
Methotrexate-based ionic liquid as a potent anticancer drug for oral delivery: In vivo pharmacokinetics, biodistribution, and antitumor efficacy.基于甲氨蝶呤的离子液体作为一种有效的口服抗癌药物:体内药代动力学、生物分布和抗肿瘤疗效。
Int J Pharm. 2021 Oct 25;608:121129. doi: 10.1016/j.ijpharm.2021.121129. Epub 2021 Sep 22.
3
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives.
离子液体和低共熔溶剂在口服药物中的作用概述
Pharmaceutics. 2025 Feb 25;17(3):300. doi: 10.3390/pharmaceutics17030300.
4
Strategies to Enhance Nanocrystal Formulations for Overcoming Physiological Barriers Across Diverse Routes of Administration.增强纳米晶体制剂以克服不同给药途径生理屏障的策略。
Int J Nanomedicine. 2025 Jan 9;20:367-402. doi: 10.2147/IJN.S494224. eCollection 2025.
5
Polymerizable Cholinium-Based Antibiotics for Polymer Carriers: Systems with Combined Load of Cloxacillin and Ampicillin.用于聚合物载体的可聚合胆碱基抗生素:氯唑西林和氨苄西林联合负载的体系
Molecules. 2024 Dec 18;29(24):5973. doi: 10.3390/molecules29245973.
6
Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives.用于糖尿病治疗的口服肽疗法:现状与未来展望。
Acta Pharm Sin B. 2024 May;14(5):2006-2025. doi: 10.1016/j.apsb.2024.02.019. Epub 2024 Feb 28.
7
Unnatural Amino Acid-Based Ionic Liquid Enables Oral Treatment of Nonsense Mutation Disease in Mice.基于非天然氨基酸的离子液体可实现对小鼠无义突变疾病的口服治疗。
Adv Sci (Weinh). 2024 Apr;11(13):e2306792. doi: 10.1002/advs.202306792. Epub 2024 Jan 30.
8
Potentials of ionic liquids to overcome physical and biological barriers.离子液体克服物理和生物屏障的潜力。
Adv Drug Deliv Rev. 2024 Jan;204:115157. doi: 10.1016/j.addr.2023.115157. Epub 2023 Dec 15.
9
A Comprehensive Review on Imperative Role of Ionic Liquids in Pharmaceutical Sciences.离子液体在药学科学中的重要作用的全面综述。
Curr Drug Deliv. 2024;21(9):1197-1210. doi: 10.2174/0115672018255191230921035859.
10
β-Glucan and Fatty Acid Based Mucoadhesive Carrier for Gastrointestinal Tract Specific Local and Sustained Drug Delivery.基于β-葡聚糖和脂肪酸的胃肠特定局部和持续药物递送的黏膜黏附载体。
Biomolecules. 2023 Apr 28;13(5):768. doi: 10.3390/biom13050768.
蛋白质和肽的口服递送:挑战、现状与未来展望。
Acta Pharm Sin B. 2021 Aug;11(8):2416-2448. doi: 10.1016/j.apsb.2021.04.001. Epub 2021 Apr 29.
4
Cholinium-based ionic liquids as bioinspired hydrotropes to tackle solubility challenges in drug formulation.基于胆碱的离子液体作为仿生增溶剂,解决药物制剂中的溶解度挑战。
Eur J Pharm Biopharm. 2021 Jul;164:86-92. doi: 10.1016/j.ejpb.2021.04.013. Epub 2021 Apr 23.
5
Improvement of New Dianionic Ionic Liquids vs Monoanionic in Solubility of Poorly Water-Soluble Drugs.新型双阴离子离子液体对改善疏水性药物溶解度的作用优于单阴离子离子液体。
J Pharm Sci. 2021 Jun;110(6):2489-2500. doi: 10.1016/j.xphs.2021.01.014. Epub 2021 Jan 21.
6
A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.用于癌症治疗和诊断的二氧化硅纳米粒子的最新技术和专利综述。
Recent Pat Drug Deliv Formul. 2020;14(2):126-144. doi: 10.2174/1872211314666200914155051.
7
Oral delivery of sorafenib through spontaneous formation of ionic liquid nanocomplexes.通过自发形成的离子液体纳米复合物实现索拉非尼的口服递送。
J Control Release. 2020 Jun 10;322:602-609. doi: 10.1016/j.jconrel.2020.03.018. Epub 2020 Mar 19.
8
What is the future for nanocrystal-based drug-delivery systems?基于纳米晶体的药物输送系统的未来如何?
Ther Deliv. 2020 Apr;11(4):225-229. doi: 10.4155/tde-2020-0016. Epub 2020 Mar 11.
9
Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy.多功能壳聚糖聚合物胶束作为口服紫杉醇递送系统,以提高生物利用度和抗肿瘤疗效。
Int J Pharm. 2020 Mar 30;578:119105. doi: 10.1016/j.ijpharm.2020.119105. Epub 2020 Feb 1.
10
Thiolated Nanoparticles Overcome the Mucus Barrier and Epithelial Barrier for Oral Delivery of Insulin.巯基化纳米颗粒克服黏液屏障和上皮屏障实现胰岛素的口服递送。
Mol Pharm. 2020 Jan 6;17(1):239-250. doi: 10.1021/acs.molpharmaceut.9b00971. Epub 2019 Dec 18.